Autophagy Improves Inflammatory Response in Sepsis Accompanied by Changes in Gut Microbiota
Mediators of Inflammation · 2024
DOI: 10.1155/2024/9550301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, 2024. Verfasst von La Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, School of Basic Medical Sciences, Guizhou University of Traditional Chinese Medicine, Guiyang, China. Hauptthemen laut MEDLINE: Autophagy, Sepsis, Gastrointestinal Microbiome, Rats, Sprague-Dawley. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Sepsis
Abstract (Originalsprache)
Background
Sepsis is defined as a life‐threatening disease. Autophagy and the microbiome are increasingly connected with sepsis. The aim of this study was to investigate the protective effect of autophagy and the possible mechanisms.
Methods
The septic rat model was established by cecal ligation perforation (CLP). Rapamycin (Rap), 3‐methyladenine (3‐MA), and chloroquine (CQ) were administered to interfere autophagy. Western blot (WB) was used to detect the expression of key proteins in autophagy. Hematoxylin and eosin (H&E) staining and enzyme‐linked immunosorbent assays (ELISAs) were used to identify the effect of autophagy on various organs. 16S ribosomal RNA gene sequencing was used to analyze the changes of the gut microbiota.
Results
Rap significantly upregulated the expression of key autophagy proteins, and 3‐MA reduced the relative expression compared to the CLP group. The autophagic flux showed a corresponding trend. Interestingly, the autophagy inducer significantly decreased the mortality and the lipopolysaccharide (LPS) level in serum compared with the CLP group. Autophagy activation significantly improves the inflammatory response in sepsis. Histopathological sections showed that CLP destroyed the tight junctions between ileal epithelial cells, while autophagy induction reversed the damage. The sequencing results showed that autophagy activation increased the alpha diversity and alterted the composition and structure of gut microbiota. The abundance of Proteobacteria was markedly decreased in the Rap group, whereas Bacteroidetes was notably increased compared with the CLP group. Additionally, the protective effect of autophagy further changed the biomarkers in the microbial community. The top 35 functions in each sample were analyzed to obtain 18 genes including RNA synthesis, ATP binding and transport, chromosome assignment, osmotic polysaccharide transport, transcytosis, and methylation.
Conclusion
Autophagy is able to improve inflammation and may directly or indirectly regulate the microbiota of septic rats. Autophagy may be an important target for future clinical interventions in the treatment of sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, School of Basic Medical Sciences, Guizhou University of Traditional Chinese Medicine, Guiyang, China.
- Cengong County People's Hospital, Kaili, China.
ORCID-Profile: La Wang, RuiXi Luo, WeiYi Tian
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, Wang, W., Jiang, G., Ke, Z., Luo, R., & Tian, W. (2024). Autophagy Improves Inflammatory Response in Sepsis Accompanied by Changes in Gut Microbiota. Mediators of Inflammation. https://doi.org/10.1155/2024/9550301
Vancouver
Wang, Wang W, Jiang G, Ke Z, Luo R, Tian W. Autophagy Improves Inflammatory Response in Sepsis Accompanied by Changes in Gut Microbiota. Mediators of Inflammation. 2024. doi:10.1155/2024/9550301
BibTeX
@article{Wang2024,
author = {Wang, La and Wang, WenJia and Jiang, GuiTong and Ke, ZunLi and Luo, RuiXi and Tian, WeiYi},
title = {Autophagy Improves Inflammatory Response in Sepsis Accompanied by Changes in Gut Microbiota},
journal = {Mediators of Inflammation},
year = {2024},
doi = {10.1155/2024/9550301}
}
EUVIMED